Alembic Pharmaceuticals Limited (BOM:533573)
India · Delayed Price · Currency is INR 797.05
-5.10 (-0.64%)
At close: Jul 31, 2026
Alembic Pharmaceuticals Market Cap
Alembic Pharmaceuticals has a market cap or net worth of 156.67 billion as of July 31, 2026. Its market cap has decreased by -20.90% in one year.
Market Cap
156.67B
Enterprise Value
168.95B
Revenue
73.45B
Ranking
n/a
PE Ratio
23.22
Stock Price
797.05
ChartMarket Cap Chart
Since September 21, 2011, Alembic Pharmaceuticals's market cap has increased from 9.00B to 156.67B, an increase of 1,640.47%. That is a compound annual growth rate of 21.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 156.67B | -5.80% |
| Dec 31, 2025 | 166.32B | -20.64% |
| Dec 31, 2024 | 209.59B | 40.41% |
| Dec 29, 2023 | 149.27B | 32.55% |
| Dec 30, 2022 | 112.61B | -28.56% |
| Dec 31, 2021 | 157.62B | -22.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 245.64B |
| Granules India | 204.20B |
| AstraZeneca Pharma India | 202.59B |
| Caplin Point Laboratories | 191.15B |
| Jubilant Pharmova | 148.07B |
| CORONA Remedies | 128.36B |
| Viyash Scientific | 110.01B |